These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
16. Inactivation of human osteosarcoma cells in vitro by 211At-TP-3 monoclonal antibody: comparison with astatine-211-labeled bovine serum albumin, free astatine-211 and external-beam X rays. Larsen RH; Bruland OS; Hoff P; Alstad J; Lindmo T; Rofstad EK Radiat Res; 1994 Aug; 139(2):178-84. PubMed ID: 8052693 [TBL] [Abstract][Full Text] [Related]
17. Astatine-211: its possible applications in cancer therapy. Brown I Int J Rad Appl Instrum A; 1986; 37(8):789-98. PubMed ID: 3021680 [TBL] [Abstract][Full Text] [Related]
18. Administered activity and metastatic cure probability during radioimmunotherapy of ovarian cancer in nude mice with 211At-MX35 F(ab')2. Elgqvist J; Andersson H; Bernhardt P; Bäck T; Claesson I; Hultborn R; Jensen H; Johansson BR; Lindegren S; Olsson M; Palm S; Warnhammar E; Jacobsson L Int J Radiat Oncol Biol Phys; 2006 Nov; 66(4):1228-37. PubMed ID: 17145538 [TBL] [Abstract][Full Text] [Related]
19. The promise of targeted {alpha}-particle therapy. Mulford DA; Scheinberg DA; Jurcic JG J Nucl Med; 2005 Jan; 46 Suppl 1():199S-204S. PubMed ID: 15653670 [TBL] [Abstract][Full Text] [Related]
20. A microdosimetric model of astatine-211 labeled antibodies for radioimmunotherapy. Humm JL Int J Radiat Oncol Biol Phys; 1987 Nov; 13(11):1767-73. PubMed ID: 3667382 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]